Product image of Linagliptin Krka D.D. (Linagliptin) supplied by GNH India

Linagliptin Krka D.D.

Active Ingredient:
Linagliptin
Origin:
EU

Linagliptin Krka D.D. (Linagliptin)

Linagliptin, the active ingredient in Linagliptin Krka D.D., is a dipeptidyl peptidase‑4 (DPP‑4) inhibitor presented as a tablet for oral use. It is indicated for the management of type 2 diabetes mellitus in adult patients.
GNH India supplies Linagliptin Krka D.D. as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Krka, D.D., Novo Mesto

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Linagliptin is used within the antidiabetic drug class to improve glycaemic control in patients with type 2 diabetes mellitus.

  • Type 2 diabetes mellitus: lowers blood glucose by enhancing insulin secretion and reducing glucagon release in a glucose‑dependent manner.

How It Works

  • Linagliptin selectively inhibits the dipeptidyl peptidase‑4 (DPP‑4) enzyme, which degrades the incretin hormones GLP‑1 and GIP. By preventing this degradation, endogenous incretin levels rise, leading to glucose‑dependent stimulation of insulin secretion, suppression of glucagon release, and overall improvement of post‑prandial and fasting glycaemia.

Side Effects

Linagliptin is generally well tolerated, but adverse reactions can occur.

Common Side Effects

  • Nasopharyngitis: mild upper‑respiratory tract infection.
  • Headache: transient and usually mild.
  • Upper respiratory tract infection: cough, sore throat.
  • Dizziness: occasional light‑headedness.
  • Gastrointestinal upset: nausea or abdominal discomfort.

Serious or Rare Side Effects

  • Pancreatitis: severe abdominal pain requiring immediate medical attention.
  • Severe allergic reactions: rash, angioedema, or anaphylaxis.
  • Hepatic dysfunction: elevated liver enzymes or hepatitis.
  • Hypoglycaemia: especially when combined with insulin or sulfonylureas.

Precautions & Warnings

Before initiating linagliptin, consider the following safety measures.

  • Renal function monitoring: use with caution in severe renal impairment.
  • Hepatic function assessment: avoid in patients with significant liver disease.
  • Hypersensitivity check: discontinue if allergic reactions occur.
  • Concomitant antidiabetic agents: adjust doses to prevent hypoglycaemia.
  • Pregnancy and lactation: safety not established; prescribe only if benefit outweighs risk.
  • Store at ambient temperature: keep in the original pack, protect from moisture and light.

Avoid Interactions

Linagliptin may interact with other medicines; awareness of the interaction level helps manage risk.

Major Interactions (Avoid)

  • Insulin or sulfonylureas: increased risk of hypoglycaemia.
  • Rifampin: may reduce linagliptin plasma concentrations.

Moderate Interactions (Monitor Closely)

  • Strong P‑gp inhibitors (e.g., itraconazole): may raise linagliptin exposure.
  • ACE inhibitors or ARBs: monitor renal function and potassium.
  • Diuretics: watch for electrolyte disturbances.
  • Warfarin: periodic INR checks are advisable.

Frequently Asked Questions

Linagliptin Krka D.D. is prescribed to improve blood‑sugar control in adults with type 2 diabetes mellitus. It works as part of a comprehensive diabetes management plan that may include diet, exercise, and other antidiabetic agents.

Linagliptin blocks the DPP‑4 enzyme, which normally breaks down the incretin hormones GLP‑1 and GIP. By preserving these hormones, the drug enhances insulin release and reduces glucagon output in response to meals, thereby lowering glucose levels.

The specific dose of Linagliptin Krka D.D. is determined by the prescribing clinician based on individual patient factors such as renal function, concomitant therapies, and glycaemic targets. Patients should follow the prescriber’s instructions exactly.

Safety data for linagliptin in pregnancy and lactation are limited. It should only be used if the potential benefit justifies the possible risk to the fetus or infant, and the decision must be made by a qualified healthcare professional.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Linagliptin shares the same class mechanism as other DPP‑4 inhibitors but is distinguished by its primarily biliary excretion, allowing use without dose adjustment in most patients with renal impairment. Efficacy and safety profiles are comparable across the class.

Store the tablets at ambient temperature, below 25 °C, in the original container. Protect them from moisture, excessive heat, and direct sunlight to maintain product stability.

Linagliptin is taken orally, usually once daily, with or without food. The tablet should be swallowed whole with water and not chewed or crushed, unless otherwise directed by a healthcare provider.

Serious adverse events include pancreatitis, severe allergic reactions such as anaphylaxis, and hepatic dysfunction. Patients should seek immediate medical attention if they experience persistent abdominal pain, rash, swelling, or signs of liver injury.

Linagliptin is contraindicated in individuals with known hypersensitivity to the drug or any of its excipients. Caution is also advised for patients with severe hepatic disease, and it should be avoided in those where the risk of hypoglycaemia cannot be safely managed.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Linagliptin

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT